More Manpower for Research

Dr. Lars Behrend joins SSS International Clinical Research and expands the executive board

Management der SSS International Clinical Research - Dr. Lars Behrend (links) und Dr. Michael Sigmund (rechts) (PresseBox) ( Germering near Munich, Germany, )
SSS International Clinical Research GmbH (SSS), an innovative and flexible partner for European-wide clinical studies, continues to expand. As of now, the founder, Dr. Michael Sigmund and the new Chief Operating Officer (COO), Dr. Lars Behrend, will be working hand-in-hand to rapidly implement the international growth strategy. The new addition to the executive board meets the needs of the growth strategy and guarantees the well-known pharmaceutical industry customers full cooperation together with a strong and long-term partner.

For more than 20 years, SSS has been successful within the area of clinical contract research (Full Service Contract Research) for the development of medicines and medical products. For further process professionalization and the development of the three subsidiaries in Germany, Poland and Romania, Dr. Michael Sigmund, until now the sole CEO of the company, has decided to bring reinforcements on board to create a future-orientated executive management.

From July 2017, Dr. Lars Behrend (45) will fill the role of COO, covering the key areas of financial management, controlling and business development. Lars Behrend holds a diploma in biology and a PhD in cancer research. He has 15 years work experience in management and consulting within the medical sector, biotechnology and cleantech areas.

“Having Dr. Lars Behrend on the team is a real stroke of luck. Here is a person who not only has extensive experience as a management executive and knows all about the clinical and biotechnology sectors. He also has a real entrepreneurial personality with hands-on experience in developing professional organisational structures and knowing the importance of cooperative customer relationships.” comments Dr. Michael Sigmund the personnel decision. “I have gained a sparring partner who exactly knows the critical phase when medicines move from theoretical research to the clinic. In future, I can concentrate more on the strategic development of our company.”
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an service@pressebox.de.